COVID-19 State Reopening Tracker
Winter is coming, and with it, another wave of new Coronavirus cases October 1, 2020 – Capstone believes states removing restrictions on indoor gatherings, entering the fall season, will lead to a third wave of new COVID-19 cases by November, possibly coinciding...
Opioid Litigation Focus Will Shift to Chain Pharmacies
Walgreens, CVS, Rite Aid, and Walmart face $30 billion-35 billion in liabilities. August 14, 2020 – Capstone believes the focus of state attorneys general and municipalities opioid litigation will shift to chain pharmacies—primarily Walgreens Boots Alliance Inc....
Emerging Privacy Legislation and its Risks to a Healthcare Tech Company’s Business Model
The Request: Capstone advised a client on the potential acquisition of a healthcare analytics company that paired bolstered, value-added overlays to healthcare provider contact data. Specifically, we analyzed regulation, legislation, and other government initiatives...
340B Reform and the Risks to a Hospital-Based Specialty Pharmacy
The Request: Capstone advised a client on the potential acquisition of a US company that provides 340B-focused retail and specialty pharmacy management. Our diligence focused on determining the likelihood, rationale, and impact of federal and state 340B reforms to the...
